Another hypotensive agent--methyldopa.
作者信息
DALEY D, EVANS B
出版信息
Br Med J. 1962 Jul 21;2(5298):156-8. doi: 10.1136/bmj.2.5298.156.
Abstract
摘要
相似文献
1
Another hypotensive agent--methyldopa.
Br Med J. 1962 Jul 21;2(5298):156-8. doi: 10.1136/bmj.2.5298.156.
2
Pharmacodynamic effects and clinical use of alpha methyldopa in the treatment of essential hypertension.
Am J Cardiol. 1962 Jun;9:863-7. doi: 10.1016/0002-9149(62)90211-4.
3
Clinical trial of a new hypotensive drug, methyldopa ("aldomet").
Med J Aust. 1962 Jul 14;49(2):52-5.
4
[Inhibition of serotonin formation by alpha-methyl-DOPA].[α-甲基多巴对血清素形成的抑制作用]
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1958;234(3):194-205.
5
[ANTIHYPERTENSIVE ACTION OF A DOPA-DECARBOXYLASE INHIBITOR: METHYLDOPA].
Farmaco Prat. 1963 Dec;18:688-93.
6
Alpha-methyldopa: antihypertensive drug with unusual mechanism of action.
Heart Bull. 1963 Jan-Feb;12:1-4.
7
ANALOGS OF METHYLDOPA AND DOPA. HYDANTOIC ACIDS AND HYDANTOINS.甲基多巴和多巴的类似物。乙内酰脲酸和乙内酰脲。
J Med Chem. 1964 May;7:379-81. doi: 10.1021/jm00333a041.
8
Comparison of centrally mediated hypotensive action of methyldopa and DOPA in cats.甲基多巴与多巴对猫中枢介导的降压作用比较
Arch Int Pharmacodyn Ther. 1973 Sep;205(1):103-13.
9
[A new-type hypotensive agent: alpha-methyl-DOPA].
Actual Cardiol Angeiol Int (Paris). 1962 Oct-Dec;11:303-6.
10
[The effect of intravenously administered DOPA on the blood pressure in pretreated alpha-methyl-DOPA hypertensives. Studies on the blood pressure-lowering mechanism of alpha-methyl-DOPA].[静脉注射多巴对预先用α-甲基多巴治疗的高血压患者血压的影响。α-甲基多巴降压机制的研究]
Klin Wochenschr. 1962 Sep 15;40:959-62. doi: 10.1007/BF01481420.
引用本文的文献
1
Methyldopa for primary hypertension.甲基多巴用于原发性高血压。
Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD003893. doi: 10.1002/14651858.CD003893.pub3.
2
METHYLDOPA IN TREATMENT OF HYPERTENSION DUE TO CHRONIC RENAL DISEASE.甲基多巴治疗慢性肾病所致高血压
Br Med J. 1964 Jan 4;1(5374):27-30.
3
Treatment of severe hypertension with methyldopa.甲基多巴治疗重度高血压。
Br Med J. 1963 Jan 19;1(5324):151-5. doi: 10.1136/bmj.1.5324.151.
4
Parkinsonism occurring with methyldopa treatment.甲基多巴治疗引发的帕金森综合征。
Br Med J. 1963 Apr 13;1(5336):1001. doi: 10.1136/bmj.1.5336.1001.
5
Double-blind trial of four hypotensive drugs (methyldopa and three sympatholytic agents).四种降压药物（甲基多巴和三种交感神经阻滞剂）的双盲试验。
Br Med J. 1967 Jun 3;2(5552):598-600. doi: 10.1136/bmj.2.5552.598.
6
Hypertension and hyperuricaemia.高血压和高尿酸血症。
Proc R Soc Med. 1966 Apr;59(4):316-9. doi: 10.1177/003591576605900407.
7
Autoimmune haemolytic anaemic complicating methyldopa therapy.甲基多巴治疗引发的自身免疫性溶血性贫血
Postgrad Med J. 1968 Jun;44(512):438-42. doi: 10.1136/pgmj.44.512.438.
8
Treatment of hypertension with methyldopa.用甲基多巴治疗高血压。
Br Med J. 1966 Jan 15;1(5480):133-7. doi: 10.1136/bmj.1.5480.133.
9
Methyldopa hepatitis. Report of three cases.甲基多巴性肝炎。3例报告。
Am J Dig Dis. 1973 Mar;18(3):213-22. doi: 10.1007/BF01071975.
10
Serum uric acid in hypertensive patients.高血压患者的血清尿酸
Br Heart J. 1975 Dec;37(12):1210-5. doi: 10.1136/hrt.37.12.1210.
本文引用的文献
1
Decarboxylase inhibition and blood pressure reduction by alpha-methyl-3,4-dihydroxy-DL-phenylalanine.α-甲基-3,4-二羟基-DL-苯丙氨酸对脱羧酶的抑制作用及降压效果
Science. 1960 Jun 24;131(3417):1890-1. doi: 10.1126/science.131.3417.1890.
2
Clinical and chemical studies with alpha-methyl-dopa in patients with hypertension.
Circulation. 1962 Feb;25:281-91. doi: 10.1161/01.cir.25.2.281.
3
Clinical and pharmacological studies with guanethidine in the treatment of hypertension.胍乙啶治疗高血压的临床与药理学研究。
Lancet. 1960 Aug 20;2(7147):381-7. doi: 10.1016/s0140-6736(60)92836-1.
4
Inhibition of dihydroxy-phenylalanine decarboxylase by derivatives of phenylalanine.
Arch Biochem Biophys. 1954 Aug;51(2):444-56. doi: 10.1016/0003-9861(54)90500-7.
Zotero 插件